3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Spinal Diseases
1
Interventions
nilotinib
2
asciminib
2
Dasatinib
2
Cyclophosphamide
2
fludarabine
1
bosutinib
1
Vincristine
1
Prednisone
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Imatinib Mesylate
1
Etoposide
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Philadelphia Chromosome
×
Magnetic Resonance Imaging
×
1 year
×
Clear all
No trials found.